Health & Biotech
Check out the latest Animal Health news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Apiam expands presence in national animal health market with Equine Clinic acquisition
Health & Biotech
PharmAust expands studies in NZ, one step closer towards a Phase 3 trial for canine cancer
Health & Biotech
Apiam confirms APVMA approval for a critical new vaccine in a major breakthrough for Australian cattle health
Health & Biotech
PharmAust makes important progress during quarter ahead of multiple clinical trials of lead drug, monepantel
Health & Biotech
Apiam expands presence in key regional Victorian hub with acquisition of Horsham Veterinary Hospital
Health & Biotech
Dairy and mixed clinics boost Apiam’s solid start to FY22 as vet network closes key acquisitions
Health & Biotech
PharmAust’s lead drug MPL step closer to COVID-19 and MND human clinical trials
Health & Biotech
PharmAust doubles life expectancy of pet dogs with cancer, a major step towards commercialisation
Health & Biotech
Merck’s COVID-19 breakthrough in the US gives boost to ASX- listed PharmAust
The Secret Broker
The Secret Broker: Possessions gonna possess
Health & Biotech
PharmAust reward loyal shareholders with attractively priced option offer
Health & Biotech
From companion to large animal care – here’s how Apiam’s knowledge of rural vet clinics is driving growth
Health & Biotech
Vets are four times more likely to die of suicide. Here’s how Apiam is tackling a troubling mental health crisis
Health & Biotech
Dairy and mixed clinics boost Apiam FY21 profits as the vet network continues regional expansion
Health & Biotech
More resources, better vets, booming profits; How Apiam is changing the game with Australia’s largest regional vet network
Health & Biotech
Apiam is staying busy in M&A as it builds a dominant regional vet network – here’s how the numbers stack up
Health & Biotech
PharmAust makes progress in the quarter as it lays the foundation for commercialisation
Stockhead TV
Q-Wrapz: Oriel Morrison interviews Roger Aston, executive chairman of PharmAust Ltd (ASX:PAA)
Health & Biotech
PharmAust files for patent on lead drug monepantel to fight viral diseases
Health & Biotech
PharmAust flags good news on key stability test for Monepantel treatment
Health & Biotech
Apiam expands equine footprint and boosts Qld growth network with new acquisition, shares climb
Health & Biotech
PharmAust achieves successful Phase II trials on monepantel for canine cancer, shares jump
Health & Biotech
Apiam delivers major boost for Australia’s $5bn pork industry with Data Pig technology platform
Health & Biotech
Executive insights: How Apiam is capitalising on the major opportunity in ‘greenfield’ vet clinics
Health & Biotech
Apiam expands dominant footprint in regional markets with major Queensland acquisition
Health & Biotech
Creso Pharma expands into Eastern Europe with animal product launch in Poland
Health & Biotech
Creso Pharma launches hemp-based product for swine, enters the lucrative livestock market
Health & Biotech
The federal government just prioritised vets on its skilled migrant list – here’s why Apiam is set to be a major beneficiary
Health & Biotech
PharmAust calls on experienced exec in push to commercialise its drug for canine cancer
Health & Biotech
Apiam gains traction with analysts, institutional investors and strategic partners as regional growth plans accelerate
News
There’s never been a more exciting time to be a pet care stock; and the ASX cohort just grew further
Health & Biotech
PharmAust passes critical milestone in Phase II study of Monepantel, sets eyes on Phase III
Health & Biotech
Big investors pile in to Apiam’s $6m funding round as its regional growth strategy accelerates
Health & Biotech
Apiam shares are up more than 30pc in 2021, as corporate investors back its aggressive growth strategy
Health & Biotech
How Apiam is using technology to revolutionise regional vet care
Health & Biotech
Creso Pharma makes plans to enter US market with new partnership
Health & Biotech
Higher profits and more dividends; Apiam’s half-year results reflect a company going from strength to strength
Health & Biotech
Apiam pounces on a generational market opportunity amid booming growth in regional Australia
Health & Biotech
Your ultimate guide to ASX pet stocks
Health & Biotech
Creso Pharma experiencing strong demand for pet-health cannabis products
Health & Biotech
How a leading Apiam vet clinic converted the COVID-19 crisis into a 20pc boost in revenues
Health & Biotech
Creso Pharma picking up steam with more orders for hemp oil pet products
Health & Biotech
Apiam snaps up key vet acquisition to capitalise on post-Covid tailwinds
Health & Biotech
For Apiam, being an employer of choice is crucial to its competitive advantage
Health & Biotech
Apiam gives Aussie farmers a boost with new piglet survival treatment
Health & Biotech
Apiam shares rally on strong Q1 numbers amid surging growth in pet ownership
Health & Biotech
CannPal Animal Therapeutics signs agreement to register doggie drug DermaCann in South Africa
Load More
